This session is sponsored by Daiichi Sankyo. Product-related information may be discussed.
Date of prep: Aug 2020
This series provides a deep dive into one specialty per month to keep our healthcare professionals up to date on the latest clinical advancements in their fields.
This webinar will focus on atrial fibrillation, blood pressure and cholesterol. You will also have the opportunity to join our five cardiology experts for a live Q&A following their presentations.
This webinar took place on 6 October 2020 and is available to watch on-demand.
Please note that this webinar is for healthcare professionals only.
Chaired by Professor Gregory Lip, Price-Evans chair of cardiovascular medicine, University of Liverpool and Liverpool Heart and Chest Hospital and senior investigator, National Institute for Health Research
6.30pm Welcome and opening remarks
Professor Cheng-Hock Toh, academic vice president, Royal College of Physicians
6.35pm ESC atrial fibrillation guidelines 2020
Professor Tatjana Potpara, consultant cardiologist, Clinical Centre of Serbia, Belgrade
6.55pm The primary and secondary care interface in hypertension
Dr Terry McCormack, general practitioner, and vice president, British and Irish Hypertension Society
Dr Michael Okorie, chair, Education Working Party, British and Irish Hypertension Society
7.15pm Lipids – from statins to PCSK9i and beyond
Dr Derek Connolly, consultant interventional cardiologist and director of research and development, Sandwell and West Birmingham Hospitals NHS Trust and honorary senior clinical lecturer, Institute of Cardiovascular Sciences, University of Birmingham
7.35pm Question and answer session
Professor Tatjana Potpara, Dr Terry McCormack, Dr Michael Okorie and Dr Derek Connolly
8.00pm End of session
Delegates will receive 2 CPD credits for attending this webinar.
RCP members price: Free
This medical education online learning module is funded by Daiichi Sankyo UK Ltd as part of a commitment towards supporting appropriate management of patients in the cardiovascular disease area. Daiichi Sankyo UK Ltd has had input into the module title and reviewed the educational content for quality, factual accuracy and compliance with the ABPI code. It is intended for HCP’s only. Prescribing Information and adverse event reporting details are available at the end of the presentation. For further information on Daiichi Sankyo UK Ltd please visit www.daiichi-sankyo.co.uk
This webinar is for health care professionals only.